Case File №
#VI-2026-0404
Oasis Peptides
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
42 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | B Good | 7 | 6.8 | 5.7 | 7.9 | 14 Jan 2025 |
| Melanotan II | C Okay | 4 | 5.8 | 5.3 | 7.1 | 19 Feb 2025 |
| BPC-157 | E Bad | 3 | 5.3 | 2.4 | 8.7 | 14 Jan 2025 |
| CJC-1295 | E Bad | 2 | 3.6 | 2.3 | 4.9 | 14 Jan 2025 |
| 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | X N/A | 1 | 5.7 | 5.7 | 5.7 | 24 Apr 2025 |
| 17a-Methyl-1-Testosterone | X N/A | 1 | 4.0 | 1.8 | 1.8 | 14 Jan 2025 |
| Adipotide | X N/A | 1 | 8.0 | 8.0 | 8.0 | 25 Apr 2025 |
| Alprostadil | X N/A | 1 | 4.6 | 4.6 | 4.6 | 14 Jan 2025 |
| Botulinum toxin | X N/A | 1 | 7.2 | 7.2 | 7.2 | 13 Jun 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 5.7 | 5.7 | 5.7 | 9 Jun 2025 |
| Cerebrolysin | X N/A | 1 | 10.0 | 10.0 | 10.0 | 3 Jul 2025 |
| Chonluten | X N/A | 1 | 4.0 | 2.9 | 2.9 | 21 May 2025 |
| CJC-1295 With DAC | X N/A | 1 | 4.0 | 3.4 | 3.4 | 16 Mar 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 4.2 | 4.2 | 4.2 | 2 Jul 2025 |
| Dianabol Oil | X N/A | 1 | 7.1 | 7.1 | 7.1 | 13 Jun 2025 |
| Enclomiphene | X N/A | 1 | 4.2 | 4.2 | 4.2 | 7 May 2025 |
| Epithalon | X N/A | 1 | 5.9 | 5.9 | 5.9 | 13 Feb 2025 |
| Estradiol Cypionate | X N/A | 1 | 6.3 | 6.3 | 6.3 | 6 May 2025 |
| Humanin | X N/A | 1 | 5.3 | 5.3 | 5.3 | 9 Jun 2025 |
| Letrozole | X N/A | 1 | 4.7 | 4.7 | 4.7 | 14 Jan 2025 |
| LGD-4033 (Ligandrol) Raw | X N/A | 1 | 6.7 | 6.7 | 6.7 | 6 May 2025 |
| Masteron P (Drostanolone P) | X N/A | 1 | 4.0 | 3.6 | 3.6 | 2 Jul 2025 |
| Methylene Blue | X N/A | 1 | 4.0 | 4.0 | 4.0 | 2 Jul 2025 |
| MT-1 | X N/A | 1 | 5.5 | 5.5 | 5.5 | 3 Jun 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 6.2 | 6.2 | 6.2 | 21 May 2025 |
| NAD+ | X N/A | 1 | 7.8 | 7.8 | 7.8 | 20 Jun 2025 |
| Ostarine (MK-2866) | X N/A | 1 | 5.6 | 5.6 | 5.6 | 9 Jun 2025 |
| Oxymetholone (Anadrol) Raw | X N/A | 1 | 5.5 | 5.5 | 5.5 | 3 Jun 2025 |
| PE 22-28 | X N/A | 1 | 4.8 | 4.8 | 4.8 | 3 Jun 2025 |
| PNC 27 | X N/A | 1 | 7.2 | 7.2 | 7.2 | 7 May 2025 |
| Proviron (Mesterolone) Raw | X N/A | 1 | 6.7 | 6.7 | 6.7 | 3 Jul 2025 |
| PTD-DBM | X N/A | 1 | 5.4 | 5.4 | 5.4 | 16 Mar 2025 |
| RAD140 | X N/A | 1 | 7.6 | 7.6 | 7.6 | 8 Jul 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 4.2 | 4.2 | 4.2 | 8 Jul 2025 |
| SNAP-8 | X N/A | 1 | 4.0 | 3.6 | 3.6 | 6 May 2025 |
| SS-31 (Elamipretide) Raw | X N/A | 1 | 6.4 | 6.4 | 6.4 | 16 Mar 2025 |
| Super Shred | X N/A | 1 | 5.3 | 5.3 | 5.3 | 28 Mar 2025 |
| T4 (Levothyroxine) | X N/A | 1 | 5.4 | 5.4 | 5.4 | 25 Apr 2025 |
| Testagen | X N/A | 1 | 4.9 | 4.9 | 4.9 | 28 Mar 2025 |
| Thymalin | X N/A | 1 | 6.9 | 6.9 | 6.9 | 3 Jul 2025 |
| Trenbolone Acetate Raw | X N/A | 1 | 6.2 | 6.2 | 6.2 | 3 Jul 2025 |
| Vitamin B12 1mg/ml | X N/A | 1 | 4.7 | 4.7 | 4.7 | 3 Jul 2025 |
Exhibit II
Evidence Log
45 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Adipotide | 7.4 A | 20mg | 17.0mg | -15.0% | 96.76% | 10xehm | Lab B | Public |
| 25 May 2026 | Alprostadil | 4.0 C | 30mg | 32.8mg | +9.3% | 97.79% | 2gy5vw | Lab E | Community |
| 25 May 2026 | Humanin | 4.0 C | 50mg | 53.6mg | +7.2% | 97.22% | hwimwj | Lab D | Public |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.6 A | 10mg | 11.4mg | +13.7% | 98.59% | 1cu9sq | Lab D | Public |
| 24 May 2026 | Epithalon | 4.4 C | 2mg | 1.8mg | -11.4% | 99.28% | r1j5xk | Lab A | Public |
| 24 May 2026 | Dianabol Oil | 6.2 A | 200mg/ml | 248.3mg/ml | +24.2% | 96.09% | fpid9q | Lab E | Public |
| 23 May 2026 | Enclomiphene | 4.0 C | 25mg | 23.8mg | -4.8% | 97.53% | d7kshr | Lab A | Public |
| 23 May 2026 | NAD+ | 8.4 A | 2mg | 2.4mg | +21.2% | 96.10% | 8yv1xh | Lab B | Public |
| 23 May 2026 | Estradiol Cypionate | 7.3 A | 250mg/ml | 274.4mg/ml | +9.7% | 99.25% | 3s4w4i | Lab E | Community |
| 21 May 2026 | 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | 5.8 B | 10g | 11.7g | +16.5% | 98.10% | d5u3rb | Lab C | Public |
| 21 May 2026 | PNC 27 | 7.1 A | 30mg | 30.9mg | +3.1% | 99.13% | brkim1 | Lab G | Community |
| 21 May 2026 | BPC157 10mg + TB500 10mg Blend | 7.9 A | 2mg | 2.0mg | +2.0% | 99.06% | eopsyj | Lab D | Public |
| 21 May 2026 | Cerebrolysin | 9.0 A | 2mg | 2.5mg | +22.9% | 95.92% | j7brto | Lab E | Public |
| 21 May 2026 | RAD140 | 6.4 A | 100mg | 123.6mg | +23.6% | 96.39% | c20soq | Lab A | Public |
| 21 May 2026 | Super Shred | 4.7 C | 100mg/ml | 102.2mg/ml | +2.2% | 99.36% | o6d115 | Lab A | Public |
| 20 May 2026 | 17a-Methyl-1-Testosterone | 4.0 C | 100mg | 123.0mg | +23.0% | 98.75% | f7x3ly | Lab D | Public |
| 20 May 2026 | SNAP-8 | 4.6 C | 20mg | 20.2mg | +0.8% | 98.32% | celxia | Lab G | Public |
| 20 May 2026 | Thymalin | 7.0 A | 2mg | 1.9mg | -4.8% | 95.26% | m6q1f3 | Lab G | Community |
| 19 May 2026 | MT-1 | 5.7 B | 5mg | 5.1mg | +2.3% | 98.81% | eqqjny | Lab G | Community |
| 29 Jan 2026 | Methylene Blue | 4.0 C | 20mg | 20.8mg | +4.1% | 95.15% | 7rlgs6 | Lab E | Public |
| 19 Jan 2026 | Vitamin B12 1mg/ml | 4.0 C | 300mg/ml | 264.9mg/ml | -11.7% | 95.44% | e9uxei | Lab F | Public |
| 9 Jan 2026 | LGD-4033 (Ligandrol) Raw | 7.6 A | 10g | 9.1g | -8.7% | 98.52% | z5nz88 | Lab A | Public |
| 9 Jan 2026 | Selank 10mg + Semax 10mg Blend | 5.6 B | 50mg | 45.1mg | -9.8% | 97.51% | vu6hc9 | Lab C | Public |
| 7 Jan 2026 | Ostarine (MK-2866) | 5.8 B | 100mg | 110.2mg | +10.2% | 98.48% | 6si542 | Lab D | Public |
| 7 Jan 2026 | Oxymetholone (Anadrol) Raw | 5.7 B | 1g | 0.9g | -5.6% | 97.47% | cs6pu1 | Lab D | Community |
| 6 Jan 2026 | CJC-1295 With DAC | 4.0 C | 5mg | 5.3mg | +6.0% | 95.73% | iv0nx6 | Lab B | Community |
| 6 Jan 2026 | PTD-DBM | 5.9 B | 5mg | 4.7mg | -6.3% | 99.83% | jkyfhh | Lab F | Public |
| 6 Jan 2026 | Testagen | 4.0 C | 10mg | 11.9mg | +18.9% | 97.18% | bq7ect | Lab B | Community |
| 17 Dec 2025 | BPC-157 | 8.7 A | 10.49mg | 10.5mgwebsite | 9.86mg | -6.0% | 99.94% | No Label / Silver Crimp / Blue Cap | Lab E |
| 12 Dec 2025 | Chonluten | 4.5 C | 20mg | 20.3mg | +1.6% | 95.45% | nhblxg | Lab E | Public |
| 12 Dec 2025 | PE 22-28 | 4.0 C | 20mg | 21.3mg | +6.5% | 99.20% | gq2yg2 | Lab A | Public |
| 5 Dec 2025 | Botulinum toxin | 7.5 A | 2mg | 2.4mg | +18.6% | 96.11% | vlvati | Lab A | Public |
| 23 Nov 2025 | DHB (1-Test Cyp) Oral | 4.0 C | 25mg | 26.2mg | +4.8% | 95.55% | 47gg6e | Lab E | Community |
| 23 Nov 2025 | Letrozole | 4.0 C | 100mg | 110.6mg | +10.6% | 99.29% | ograyu | Lab C | Public |
| 17 Nov 2025 | Proviron (Mesterolone) Raw | 8.1 A | 1g | 1.2g | +23.6% | 95.20% | rasjod | Lab C | Public |
| 17 Nov 2025 | T4 (Levothyroxine) | 5.2 B | 20mg | 18.5mg | -7.7% | 95.24% | nugrcs | Lab E | Public |
| 17 Nov 2025 | Trenbolone Acetate Raw | 4.9 C | 500g | 483.9g | -3.2% | 98.07% | n9o64w | Lab B | Community |
| 17 Oct 2025 | Masteron P (Drostanolone P) | 5.9 B | 100mg/ml | 109.6mg/ml | +9.6% | 96.62% | 6imayl | Lab A | Community |
| 17 Oct 2025 | SS-31 (Elamipretide) Raw | 6.2 A | 1g | 1.0g | +3.1% | 98.22% | wngqnp | Lab E | Public |
| 24 Jul 2025 | Retatrutide | 5.7 C | 5mg | (no batch claim) | 5.72mg | +14.4% | 99.91% | Grey Label / Silver Crimp / Red Cap | Lab A |
| 20 Mar 2025 | Retatrutide | 6.3 B | 10mg | (no batch claim) | 11.1mg | +11.0% | 99.93% | Grey Label / Silver Crimp / Pink Cap | Lab B |
| 27 Feb 2025 | Retatrutide | 7.9 A | 10mg | (no batch claim) | 9.98mg | -0.2% | 99.87% | Grey Label / Silver Crimp / Pink Cap | Lab A |
| 19 Feb 2025 | Melanotan II | 5.3 C | 10mg | (no batch claim) | 11.57mg | +15.7% | 99.80% | Grey Label / Silver Crimp / Yellow Cap | Lab A |
| 19 Feb 2025 | Melanotan II | 5.4 C | 10mg | (no batch claim) | 9.6mg | -4.0% | 98.39% | Grey Label / Silver Crimp / Yellow Cap | Lab B |
| 19 Feb 2025 | Melanotan II | 7.1 A | 10mg | (no batch claim) | 9.87mg | -1.3% | 99.52% | Grey Label / Silver Crimp / Yellow Cap | Lab B |
— END OF EVIDENCE LOG —